JAZZ Venture Partners
Overview
JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world. The firm targets early- and growth-stage companies that leverage technology, science, and humanity to improve how we live, work, and experience the world. It offers financial investment and strategic support to innovative companies developing products and services that unlock human potential and address challenges in enterprise, wellness, healthcare, and consumer markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Transcripta Bio | Jul 2026 | Early Funding | Co-investor |
| Magnus Medical | May 2025 | Series B | Co-investor |
| Heidi Health | Mar 2025 | Series A | Co-investor |
| Eternal | Jan 2025 | Seed | Co-investor |
| Eternal | Jan 2025 | Seed | Co-investor |
Key People
Adam Gazzaley
Co Founder and Chief Scientist
Andrew Firlik
Co-Founder and Managing Partner
John F. Harris
Co-Founder and Managing Partner
John Spinale
Managing Partner
Zack Lynch
Managing Partner
Chit-Kwan Lin
Venture Partner
Ido Leffler
Venture Partner
Sharon Knight
Venture Partner
Justin Nuñez
Partner
Matt Wan
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
